Document is current
Any future updates will be listed below
-
Authors
Hines, Rochelle M. https://orcid.org/0000-0002-0459-7911
Maric, Hans Michael https://orcid.org/0000-0002-2719-4752
Hines, Dustin J.
Modgil, Amit
Panzanelli, Patrizia
Nakamura, Yasuko
Nathanson, Anna J.
Cross, Alan
Deeb, Tarek
Brandon, Nicholas J.
Davies, Paul
Fritschy, Jean-Marc https://orcid.org/0000-0002-8552-3702
Schindelin, Hermann https://orcid.org/0000-0002-2067-3187
Moss, Stephen J.
-
Funding
Funding for this research was provided by:
Canadian Institutes for Health Research Postdoctoral Fellowship
German Excellence Initiative Fellowship
Heart and Stroke Foundation of Canada (Fellowship)
Deutsche Forschungsgemeinschaft (FZ 82)
Deutsche Forschungsgemeinschaft (SFB 487 C7)
Deutsche Forschungsgemeinschaft (SCHI 425/8-1)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS101888)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS081735)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS087662)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH097446)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH106954)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA037170)
- License Information
-
More Information
Article History
Received: 4 December 2017
Accepted: 5 July 2018
First Online: 7 August 2018
Change Date: 5 September 2018
Change Type: Update
Change Details: This Article was originally published without the accompanying Peer Review File. This file is now available in the HTML version of the Article; the PDF was correct from the time of publication.
Competing interests
: S.J.M. serves as a consultant for SAGE Therapeutics and AstraZeneca, relationships that are regulated by Tufts University. The remaining authors declare no competing interests.
